Clinical Trial Update: Dapagliflozin in Patients With Critical Illness [Phase 3]

View source ↗

Summary

Phase 3 trial update for dapagliflozin in critically ill patients with sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Sepsis

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Critical Illness, Sepsis | Phase 3 | Status: COMPLETED